PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...
AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...
Harrison, S.A., Mehta, S.S. et al. Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis. Nat Med 31, 315–322 (2025). Company Contact ...
HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...
Metabolic dysfunction-associated steatohepatitis (MASH ... such as AI-based digital pathology solutions, to improve the assessment of treatment response and disease severity in MASH.
Histoindex Pte Ltd. launched its laboratory-developed test for metabolic dysfunction-associated steatohepatitis (MASH), ...
The Artisan International Small-Mid Fund portfolio outperformed the MSCI ACWI ex USA SMID Index in Q4 of 2024. Click here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback